Trastuzumab

Common brands: Herceptin, Herzuma, Ontruzant, Perjeta, Docetaxel

Top reporter: Genentech, Inc.

HER2/neu Receptor Antagonist [EPC]Microtubule Inhibitor [EPC]Nucleoside Metabolic Inhibitor [EPC]Platinum-based Drug [EPC]Aromatase Inhibitor [EPC]
67,214
Total Reports
27,424
Serious Reports
8,113
Death Reports
30
Reported Reactions
Death Report Ratio: High (12.07%)

Patient Demographics

Male
4,035
Female
53,875

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Trastuzumab.

# Reaction Reports % of Total
1 DIARRHOEA 6,668
8.9%
2 ALOPECIA 4,990
6.6%
3 NAUSEA 4,519
6.0%
4 FATIGUE 4,320
5.7%
5 OFF LABEL USE 4,247
5.6%
6 DEATH 3,584
4.8%
7 DISEASE PROGRESSION 3,492
4.6%
8 VOMITING 3,018
4.0%
9 MYELOSUPPRESSION 2,911
3.9%
10 DYSPNOEA 2,798
3.7%
11 PYREXIA 2,581
3.4%
12 ASTHENIA 2,296
3.1%
13 NEUTROPENIA 2,215
2.9%
14 NEUROPATHY PERIPHERAL 2,100
2.8%
15 PAIN 2,060
2.7%
16 EJECTION FRACTION DECREASED 2,034
2.7%
17 ANAEMIA 1,926
2.6%
18 RASH 1,851
2.5%
19 HEADACHE 1,775
2.4%
20 DECREASED APPETITE 1,579
2.1%
21 FEBRILE NEUTROPENIA 1,539
2.0%
22 METASTASES TO CENTRAL NERVOUS SYSTEM 1,535
2.0%
23 HAIR COLOUR CHANGES 1,509
2.0%
24 HAIR TEXTURE ABNORMAL 1,508
2.0%
25 MADAROSIS 1,425
1.9%
26 MALIGNANT NEOPLASM PROGRESSION 1,420
1.9%
27 HAIR DISORDER 1,370
1.8%
28 COUGH 1,352
1.8%
29 CHILLS 1,341
1.8%
30 THROMBOCYTOPENIA 1,310
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.